Shopping Cart
- Remove All
- Your shopping cart is currently empty
RO-7 is a next-generation polymerase (PA) endonuclease inhibitor of influenza A and B viruses.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,970 | 8-10 weeks | |
50 mg | $2,580 | 8-10 weeks | |
100 mg | $3,400 | 8-10 weeks |
Description | RO-7 is a next-generation polymerase (PA) endonuclease inhibitor of influenza A and B viruses. |
In vitro | RO-7 is a potently inhibits influenza virus replication and belongs to a new class of drugs in late-stage clinical trials with treatment of influenza virus infection, with anti-influenza activity in vitro and protects mice from lethal challenge with both influenza A and B viruses. |
In vivo | RO-7 keeps mice from lethal challenge with both influenza A and B viruses. |
Molecular Weight | 487.49 |
Formula | C24H20F3N3O3S |
Cas No. | 1370241-45-4 |
Relative Density. | 1.54 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.